Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Fund Details
Upturn AI Summary
AOT Growth and Innovation ETF(AOTG)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for AOTG
10/12/2026: AOTG (2-star) has a low Upturn Star Rating. Not recommended to BUY.
The AOT Growth and Innovation ETF is an actively managed fund designed to provide exposure to companies driving transformative change across various sectors, primarily technology and healthcare. Its main strength lies in its active approach, which allows it to curate a portfolio of high-growth potential stocks often missed by broader indices. It is best used as a tactical growth component within a diversified portfolio rather than a core holding, given its concentration risks. Investors should monitor valuation levels and interest rate trends closely, as these are primary catalysts for its performance. This ETF is most suitable for long-term investors comfortable with high volatility who seek to outsource the stock selection of innovation leaders.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The fund's focus on innovative, high-growth companies aligns perfectly with aggressive growth objectives. |
| Momentum investor | Strong fit while signal remains positive | Momentum investors may find the fund useful during periods of market optimism for innovative tech. |
| Value investor | Weak fit | The focus on innovation often leads to high valuation multiples which contrast with value-based strategies. |
| Dividend/Income investor | Weak fit | The fund prioritizes capital appreciation in growth companies over dividend generation. |
| Low-risk investor | Weak fit | The inherent volatility of growth and innovation stocks makes this unsuitable for conservative risk profiles. |
Investor Profile
Ideal Investor Profile
Growth-oriented investors with a high risk tolerance and a multi-year investment horizon.
Suitability
Best suited for long-term growth investors who believe in active selection of innovative companies.
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Volatility | High | High-growth sectors often experience significant price fluctuations in response to market news. |
| Market risk | Medium / high | Broader economic downturns disproportionately affect speculative growth-oriented portfolios. |
| Concentration | Medium / high | A focused portfolio may lack the diversification benefit of broader index funds. |
| Tracking/expense | Medium | Active management fees can erode returns relative to passive alternatives over long horizons. |
| Liquidity | Medium | Smaller AUM may lead to wider spreads and difficulty in executing large trades. |
| Business/sector quality | Medium / high | Success depends on the long-term viability of the specific innovative technologies selected. |
Risk Analysis
Volatility
AOTG shows high volatility consistent with high-beta, growth-oriented investment strategies.
Market Risk
Exposure to market risk is significant due to the fund's concentration in sectors susceptible to macroeconomic shifts.
What the ETF Owns
| Exposure Type | Exposure | Weight (%) | Retail Investor Read |
|---|---|---|---|
| Sector | Technology and Software | 45 | High exposure to tech firms provides growth potential through scalable innovation. |
| Sector | Healthcare and Biotechnology | 25 | Investments in health innovation capitalize on advancements in life sciences. |
| Sector | Consumer Discretionary | 20 | Targets companies disrupting traditional consumer spending models. |
| Cash/collateral | Cash and Cash Equivalents | 10 | Maintains liquidity for tactical trading and management of daily fund flows. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type ETF | Historic Profit 66.35% | Avg. Invested days 68 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | ETF Returns Performance  5.0 |
| Profits based on simulation | Last Close 10/12/2026 |
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.